Services

Move from opportunity to a defined, reviewable route.

NovaPharm's service model is organised around the decisions required for responsible UK pharmaceutical market entry and supply-chain development.

Discuss a requirement

What we do

A concise service model with deeper evidence where it matters.

  1. 01

    Opportunity assessment

    Clarify target market, product rights, evidence, commercial question and decision owner.

  2. 02

    Qualified sourcing

    Assess manufacturer, wholesaler and product-source pathways without lowering the evidence threshold.

  3. 03

    Market-entry planning

    Connect regulatory route, quality responsibilities, supply model and launch dependencies.

  4. 04

    Partner due diligence

    Review authority, scope, technical fit, documentation and oversight requirements.

  5. 05

    Launch readiness

    Make unresolved product, regulatory, quality, logistics and account dependencies visible.

  6. 06

    Controlled account service

    Prepare governed B2B onboarding and evidence access for a managed production environment.

Operating sequence

Frame. Qualify. Govern. Release only when ready.

  1. 01Frame the decision
  2. 02Establish evidence
  3. 03Assign responsibility
  4. 04Control implementation
  5. 05Verify readiness

Tell us which decision needs to be made.

Contact NovaPharm